Eppendorf has launched the first centrifuge on the market to be deemed sustainable under the My Green Lab ACT label. We ask the firm what this means, and how it plays into wider sustainability goals. The concept of sustainability has moved beyond a tick-box exercise within the bioprocess industry. Last year, vendors took note as pharma giant GSK launched a sustainability program calling on its network of over 160 suppliers to take action on sustainability commitments and make improvements on emissions, energy, heat,…
Friday, May 12, 2023 Daily Archives
Waters hopes for bioanalytic windfall after $1.36bn deal bring light scattering
The impending acquisition of light scattering technology and software firm Wyatt will help Waters play in the $1.8 billion bioanalytical characterization market for new modalities, the firms says. In February, life sciences firm Waters Corporation announced its intentions to buy Wyatt Technology for $1.36 billion. When the deal closes – expected before the end of June – Waters will add the Santa Barbara, California-based family firm with a workforce of more than 200 employees and a range of bioanalytical technologies.…
Expert: Synthetic promoters for transcription the ‘foundation of modern biotech’
Synthetic biology could be used to develop a new paradigm in controlling cellular function and specificity, according to a bioprocess engineer at BPI Europe.  Speaking at the event in Amsterdam, The Netherlands this week, David James, professor of bioprocess engineering at the University of Sheffield, told delegates the manufacturability of biotherapeutics can be enhanced by synthetic biology through the design of specific genetic systems. Chinese hamster ovary (CHO) cells are a workhorse in biomanufacturing, used to produce large quantities of…